DIPLOMAT PHARMACY INC's ticker is and the CUSIP is 25456K951. A total of 4 filers reported holding DIPLOMAT PHARMACY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $142,000 | +10.1% | 35,600 | +35.4% | 0.00% | 0.0% |
| Q3 2019 | $129,000 | -68.6% | 26,300 | -61.0% | 0.00% | -75.0% |
| Q2 2019 | $411,000 | +13.2% | 67,500 | +8.0% | 0.00% | 0.0% |
| Q1 2019 | $363,000 | +327.1% | 62,500 | +892.1% | 0.00% | +300.0% |
| Q4 2018 | $85,000 | -73.1% | 6,300 | -61.3% | 0.00% | -50.0% |
| Q3 2018 | $316,000 | +2006.7% | 16,300 | +2616.7% | 0.00% | – |
| Q2 2018 | $15,000 | -78.3% | 600 | -82.4% | 0.00% | -100.0% |
| Q1 2018 | $69,000 | -61.0% | 3,400 | -61.4% | 0.00% | 0.0% |
| Q4 2017 | $177,000 | +555.6% | 8,800 | +576.9% | 0.00% | – |
| Q3 2017 | $27,000 | +8.0% | 1,300 | -23.5% | 0.00% | – |
| Q2 2017 | $25,000 | -47.9% | 1,700 | -43.3% | 0.00% | -100.0% |
| Q1 2017 | $48,000 | -9.4% | 3,000 | +57.9% | 0.00% | 0.0% |
| Q3 2016 | $53,000 | +1225.0% | 1,900 | +1800.0% | 0.00% | – |
| Q2 2016 | $4,000 | -98.2% | 100 | -98.8% | 0.00% | -100.0% |
| Q1 2016 | $225,000 | +134.4% | 8,200 | +192.9% | 0.00% | +200.0% |
| Q4 2015 | $96,000 | +231.0% | 2,800 | +180.0% | 0.00% | – |
| Q3 2015 | $29,000 | -76.8% | 1,000 | -64.3% | 0.00% | -100.0% |
| Q2 2015 | $125,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 6,300 | $85,000 | 0.00% |
| SIMPLEX TRADING, LLC | 6 | $8,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 100,000 | $1,346,000 | 0.00% |